Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells
Sarah Jurmeister(Sarah Cannon Research Institute), Lee G.D. Fryer(Hammersmith Hospital)
Cited by 24
Related Papers
The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways
|Journal of Biological Chemistry|2002|1k
Identification of potential therapeutic targets in prostate cancer through a cross‐species approach
|EMBO Molecular Medicine|2018|44